Pacific Biosciences of California (PACB) 10-Q2018 Q1 Quarterly report

Filed: 2 May 18, 5:04pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Good

New words: abroad, added, adding, answer, antitrust, appeal, appealing, arrangement, budgeting, bundled, burn, capture, catch, category, China, Chinese, Circuit, coincide, commensurate, Commerce, concurrent, concurrently, conference, convince, cyclical, declaratory, deficit, deployment, diplomatic, dispute, distinct, distributor, divisional, documentation, duration, EP, EU, Europe, expedient, extra, fewer, forfeit, GDPR, geographic, hearing, holiday, inadequate, inclusion, inequitable, inter, interim, invoiced, judgement, led, lessee, likelihood, Lunar, newly, noncancelable, nullity, overturning, package, penetrate, phasing, proceeding, pronounced, provisional, quantifying, reconciling, reexportation, region, regional, renegotiate, request, reserved, royalty, RSU, ruling, sanctioned, satisfaction, seasonal, seasonality, shown, sought, SSP, standalone, standing, struggle, subsidiary, substance, superseded, Treasury, trial, UK, unacceptable, unfavorable, unspent, unused, unvested, vest, vested, vesting, yearly

Removed: affiliated, afforded, amend, approximated, architectural, bifurcated, building, collected, commence, congressional, consecutive, considerable, convenience, convention, cooperation, cure, deliverable, description, doubt, earlier, eligible, embedded, essentially, exceed, exceeding, exercisable, extend, extension, final, flat, footprint, forward, fourth, Genia, headcount, initially, Innovation, involvement, isolation, Israel, leasehold, lessor, LLC, loan, meant, midst, milestone, mitigate, move, moved, owner, Peninsula, presidential, project, proportional, prospective, real, recent, reclassified, reexamination, reflecting, relocated, retained, revalued, revised, schedule, simplify, steering, structural, structure, subsequent, substantive, substitute, supplement, thereon, thereunder, throughput, transitioning, unamortized, unattractive, underestimate, warrant, wholly, windfall

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated PACB transcripts

PACB similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Certification of CFO Furnished Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant To

Section 906 of The Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Pacific Biosciences of California, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2018, as filed with the Securities and Exchange Commission on the date hereof, I, Susan Barnes, Chief Financial Officer of the Company, certify for the purposes of section 1350 of chapter 63 of title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,

(i) the Quarterly Report of the Company on Form 10-Q for the period ended March 31, 2018 (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: May 2, 2018	/s/ Susan K. Barnes
	Susan K. Barnes
	Executive Vice President, Chief Financial Officer & Principal Accounting Officer (Principal Financial Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.